What Happens Next? Value Assessment, Drug Pricing Policy, and the R&D Pipeline
Wednesday, June 8, 12 p.m. ETPanelists
Joshua Cohen
Deputy Director, Center for the Evaluation of Value and Risk in Health at Tufts Medical Center
Jeffrey L. Handwerker
Partner, Arnold & Porter
Anna Kaltenboeck
Senior Health Advisor, US Senate Committee on Finance
Moderator
Noam Kirson
Managing Principal, Analysis Group